A Novel Pathogenic Variant in PAX8 Leads to Familial Congenital Hypothyroidism

Thyroid. 2022 Aug;32(8):1000-1002. doi: 10.1089/thy.2022.0117. Epub 2022 Jul 19.

Abstract

We report a 10-month-old girl with familial congenital hypothyroidism harboring a novel heterozygous pathogenic variant in the paired DNA-binding domain of PAX8 (NM_003466:c.110T>C:p.Leu37Pro). Genotype-phenotype correlation revealed complete penetrance of this PAX8 defect in this family, in which the affected father and half-brother carry the same mutation. This deleterious variant has not been reported in any of the available databases [MAFgnomAD = 0, dbSNP (-)], and the amino acid leucine at position 37 is highly conserved across species. Establishing the molecular diagnosis expands our knowledge on the cause of thyroid dysgenesis and provides a guide for counseling and early treatment.

Keywords: PAX8; congenital hypothyroidism; paired DNA-binding domain; pathogenic variant.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Congenital Hypothyroidism* / genetics
  • Female
  • Humans
  • Infant
  • Male
  • Mutation
  • PAX8 Transcription Factor / genetics
  • Paired Box Transcription Factors / genetics
  • Paired Box Transcription Factors / metabolism
  • Thyroid Dysgenesis* / genetics

Substances

  • PAX8 Transcription Factor
  • PAX8 protein, human
  • Paired Box Transcription Factors